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 Abstract  
Objective: High blood pressure (BP) is associated with reduced pain sensitivity, known as BP-related 
hypoalgesia. The underlying neural mechanisms remain uncertain, yet arterial baroreceptor signaling, 
occurring at cardiac systole, is implicated. We examined normotensives using functional neuroimaging 
(fMRI) and pain stimulation during distinct phases of the cardiac cycle to test the hypothesized neural 
mediation of baroreceptor-induced attenuation of pain. 
 
Methods: Eighteen participants (10 women; 32.7 ± 6.5 years) underwent BP monitoring over one week 
at home, and individual pain thresholds were determined in the lab.  Subsequently, participants were 
administered unpredictable painful and non-painful electrocutaneous shocks (stimulus type), timed to 
occur either at systole or diastole (cardiac phase) in an event-related design. After each trial, 
participants evaluated their subjective experience.  
 
Results: Subjective pain was lower for painful stimuli administered at systole compared to diastole, F1, 
2283 = 4.82; p = 0.03. Individuals with higher baseline BP demonstrated overall lower pain perception, 
F1, 2164 = 10.47; p < 0.0001. Within the brain, painful stimulation activated somatosensory areas, 
prefrontal cortex, cingulate cortex, posterior insula, amygdala, and the thalamus. Stimuli delivered 
during systole (concurrent with baroreceptor discharge) activated areas associated with heightened 
parasympathetic drive. No stimulus type x cardiac phase interaction emerged except for a small cluster 
located in the right parietal cortex. 
 
Conclusions: We confirm the negative associations between BP and pain, highlighting the 
antinociceptive impact of baroreceptor discharge.  Neural substrates associated with baroreceptor/BP-
related hypoalgesia include superior parietal lobule, precentral and lingual gyrus, regions typically 
involved in the cognitive aspects of pain experience. 
Key words: Blood Pressure, Hypoalgesia, Pain, Baroreceptors; fMRI. 
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 Acronyms: BP = blood pressure; BMI = body mass index; fMRI = functional magnetic resonance 
imaging; STAI = Spielberger Trait Anxiety Inventory; CES-D = Center for Epidemiologic Studies 
Depression Scale; PCS = Pain Catastrophizing Scale; BPI = Brief Pain Inventory; ECG = 
electrocardiogram; VAS = Visual Analog Scale; BOLD = Blood-Oxygen-Level Dependent; SD = 
Standard Deviation; SBP = Systolic Blood Pressure; ANOVA = Analysis of Variance; CAN = Central 
Autonomic Network.   
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 INTRODUCTION 
Blood pressure (BP) elevation is associated with decreased pain, termed BP-related hypoalgesia. 
This phenomenon is observed in preclinical studies of rodents (1), in unmedicated hypertensive patients 
(2), and people with family history of hypertension (3). BP-related hypoalgesia is elicited by 
spontaneous (4) or experimentally-induced BP increases (5) in normotensive individuals, and is 
reported in infants and adolescents (6,7). 
 
However, debate remains regarding the concept of BP-related hypoalgesia, and its reliability (2,8). 
Not all animal or human studies reproduce BP-related hypoalgesia (9-11). To complicate matters, the 
relationship between hypertension and pain sensitivity appears reversed in patients with chronic pain 
disorders (12).  
 
Importantly, pain is a critical signal of acute cardiovascular pathology (e.g. angina). BP-related 
hypoalgesia may make „at-risk‟ hypertensive individuals less aware of vital symptoms. Indeed, reduced 
pain interferes with early detection of silent (asymptomatic) myocardial ischemia and infarction; 
conditions are nearly twice as common in hypertensives (13). Moreover, in coronary artery disease, BP 
at rest and during physical activity shows an inverse relationship with chest pain (14,15). Longitudinal 
studies suggest a pathophysiological link between hypertension and hypoalgesia (16), indicating that 
elevated BP may be caused by, rather than be a consequence of, reduced pain (8). Plausibly, 
hypertension develops through instrumental learning, reinforced by the associated reduction in pain (1). 
 
The neural mechanisms underlying BP-related hypoalgesia are unclear. Arterial baroreceptors are 
implicated. These mechanoreceptors, in the aortic arch and carotid sinus, drive the afferent component 
of the baroreflex regulation of BP (17). First, artificial stimulation of carotid baroreceptors results in 
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 reduced pain perception in hypertensives and normotensives (18). Second, natural stimulation of 
baroreceptors by increases in BP during cardiac systole is associated with dampened pain and 
nociception (19-21). Third, pharmacological denervation of baroreceptors blocks the BP-pain 
association (1). Lastly, the same set of brain regions (periaqueductal gray, amygdala, insula) are 
implicated in both baroreceptor control and pain processing (22,23). These observations do not 
however prove causality. 
 
Hypertension is a leading cause of death worldwide motivating the need to define the mechanisms 
linking BP to pain.  Focusing on the putative role of baroreceptor signaling, we examined normotensive 
individuals, obtaining subjective and neural correlates of pain. Pain stimulation was delivered to 
coincide with the presence or absence of natural phasic baroreceptor activation; i.e. at ventricular 
systole during the ejection of blood from the heart, or at diastole when spontaneous baroreceptor 
activity is minimal. We tested the hypothesis that systolic baroreceptor signals attenuate subjective and 
neural correlates of pain. Moreover, we predicted that this effect is amplified in individuals with higher 
BP and that, at a neural level, the activity of brainstem autonomic nuclei, amygdala, and anterior insula 
mediates this BP-related hypoalgesia (23). 
 
METHODS AND MATERIALS 
Participants  
Hospital employees and students were invited to participate in a study of “the physiological 
correlates of pain”. Of 22 participants who agreed to take part, four did not meet inclusion criteria (n = 
2) or were excluded from the analyses due to technical problems (n = 2). The final sample consisted of 
18 right-handed normotensive participants (10 women; mean age 32.7 ± 6.5 years; range: 24-42 years). 
All subjects were White. Exclusionary criteria, assessed during a pre-screening questionnaire, were: 
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 doctor diagnosis of hypertension; history of cardiovascular disease, diabetes, liver or kidney disorders, 
or opiate dependence; diagnosis of psychiatric disorders (current and/or past); use of anti-hypertensive 
medications or narcotics, use of drugs/medications that might affect cardiovascular function; obesity 
(body mass index > 30 kg/m2); menopause; use of oral contraceptives during the previous 6 months, 
and pregnancy or childbirth within the last 12 months. Participants were compensated (€30) for their 
time.  The research protocol was approved by the Bioethical Committee of Santa Lucia Foundation 
(CE/PROG 523). 
 
Procedure 
Data collection occurred between November 2016 and February 2017. After eligibility assessment, 
the fMRI session appointment was scheduled. Participants were asked to refrain from alcohol and use 
of analgesic or anti-inflammatory medications for 24 hours prior to the study; and from caffeine, 
alcohol, and vigorous exercise for two hours before the experiment. To avoid circadian influences, all 
sessions were scheduled in the afternoon.  Participants came to the lab, read and signed the informed 
consent form, and completed socio-demographic and psychometric questionnaires. They then entered 
the MRI scanner room, were instrumented for physiological recording, and underwent pain threshold 
assessment, following which the imaging protocol started. At the end of the session, participants were 
instructed how to perform daily self-measurement of BP. After one week of home BP assessment, they 
returned the BP device to the laboratory, were debriefed, and received monetary compensation. 
 
Psychometric Questionnaires  
A set of standardized questionnaires were administered to investigate whether pain ratings were 
associated with specific psychological traits: a) Spielberger Trait Anxiety Inventory (STAI) (24) as a 
measure of dispositional anxiety (Cronbach‟s α = 0.87); b) Center for Epidemiologic Studies 
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 Depression Scale (CES-D) (25) as a measure of depressive symptoms (α = 0.85); c) Pain 
Catastrophizing Scale (PCS) (26) as a measure of exaggerated and ruminating negative cognitions and 
emotions during pain (Total score: α = 0.88; Helplessness subscale: α = 0.84; Rumination subscale: 
0.75; Magnification subscale α = 0.63); and d) Brief Pain Inventory (BPI) (27) as a measure of 
participants‟ pain on the day of the experimental session (α = 0.69). 
 
Home BP assessment 
Following NICE guidelines for home BP assessment (28), participants recorded two morning and 
two evening BP readings for one week using an electronic self-measurement device that transmitted 
measurement data to a remote server via 3G/GPRS connection for storage and analysis (MyPress; 
Cardionica, Italy). 
 
Physiological signal acquisition 
Electrocardiogram (ECG), pulseoximetry, respiration, and electrical stimulation current pulses 
were recorded simultaneously with fMRI  (Biopac Systems Ins, USA) and stored on a PC using a NI-
cRIO 9911 system (National Instrument, USA). 
 
Real time ECG R-wave detection and stimuli synchronization were implemented using custom 
software (LabVIEW 2011, National Instruments, USA) on the cRIO.  QRS detection from the ECG 
used a derivative + threshold algorithm from lead II. 
 
Pain threshold determination and electrocutaneous stimulation 
Pulses of electrocutaneous stimulation were delivered to the left lateral antebrachial cutaneous 
nerve with two Ag-AgCl electrodes using the Biopac System. To determine pain threshold, participants 
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 rated the intensity of sequential stimulation on a 10-point intensity rating scale (0 = don‟t feel anything, 
9 = very painful). Pulse duration was 5 ms and the intensity was increased at a constant rate until a 
rating of 9 (very painful) was obtained. The process was then repeated with decreasing steps at the 
same rate (2 increasing and 2 decreasing ramps). 
 
During the fMRI session, each pulse had a fixed duration of 5 ms and variable amplitude according 
to the participant‟s pain threshold (i.e. 80% and 200% of average pain threshold for non-painful and 
painful stimuli, respectively). The actual current delivered for each pulse was measured using a current 
probe (80i-110s AC/DC Current Probe, Fluke, USA). Pulses were delivered either at late diastole (on 
the R-wave) or at ventricular systole (300 ms after the R-wave). R-wave detection and pulse 
synchronization were displayed online on a PC screen for visual checking. The average current 
provided was 22.2 mA and the maximum stimulation intensity was 40 mA. 
 
Experimental task and fMRI paradigm 
Participants lay within the scanner bore in low light. They were instructed to focus on a central 
fixation point and wait for the upcoming sensory stimulus (electrocutaneous pulse). All visual stimuli 
were projected onto a translucent screen at the back of the MR bore and were visible through a mirror 
mounted on the head coil. At the beginning of each block, a white central fixation point was displayed 
on a black background for 6, 8, 10 or 12 s and was followed by a 5 ms electric pulse. Each of these 
time lags was used for each experimental condition and pseudo-randomized across trials. There was a 2 
s interval between the stimulus delivery and the start of the VAS rating. The VAS consisted of a green 
horizontal bar (visual angle = 12°) displayed for 3 s at the center of the screen. Nine equidistant white 
ticks were depicted below the horizontal bar associated with nine white digits. The digits 1 to 9 were 
depicted from the left to the right and were used to rate increases in pain intensity from “Not painful at 
all” to “Very painful”. These two descriptors were displayed at the left and right side of the bar. When 
Copyright © 2018 by the American Psychosomatic Society. Unauthorized reproduction of this article is prohibited.
AC
CE
PT
ED
 the rating scale appeared on screen, a small white asterisk was displayed at the center of the bar, 
corresponding to a score of 5. Participants rated the peak pain intensity by pressing the right button 
with their right middle finger to move the asterisk towards the right side of the bar (higher pain scores), 
and the left button with their right index finger to move it toward the left side of the bar (lower pain 
scores). 
 
All participants underwent two fMRI scanning runs (lasting approximately 15 min). Each fMRI 
run comprised 64 trials consisting of 32 unpredictable pain and 32 non-pain stimuli, timed to occur 
either at systole (n = 16 pain, n = 16 non-pain) or diastole (n = 16, n = 16 non-pain).  
 
Image acquisition and preprocessing 
Functional neuroimaging datasets were acquired with using a 3T Allegra scanner (Siemens, 
Erlangen, Germany). Blood oxygenation level dependent (BOLD) contrast was obtained using echo-
planar T2*-weighted imaging (EPI). The acquisition of 32 transverse slices (2.5 mm thick, 50% 
distance factor), with a repetition time of 2.08 sec, provided coverage of whole brain. The in-plane 
resolution was 3 x 3 mm.  
 
The fMRI datasets were processed with SPM12 (www.fil.ion.ucl.ac.uk). The first four image 
volumes of each run were discarded to allow for stabilization of longitudinal magnetization. The 
remaining 858 volumes were realigned with the first volume and the acquisition timing was corrected 
using the middle slice as reference. To allow inter-subject analysis, all images were normalized to the 
Montreal Neurological Institute (MNI) standard space (29), using the mean of all 858 images. All 
images were smoothed using an isotropic Gaussian kernel (full width at half maximum = 8 mm).  
Caution taken to avoid the impact of head movements and any shift between the onset of all the 
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 relevant events, and reasons to exclude biases due to pulsatile movements in the brain are detailed in 
the supplementary material (Text, S1 and S2, in Supplemental Digital Content, 
http://links.lww.com/PSYMED/A463). 
 
Behavioral data  
Behavioral data are expressed as means ± SD.  Differences at p < 0.05 were regarded as significant. 
 
Analyses were performed with the software modules of SPSS 23 (IBM) and SAS Institute.  First, 
sex differences were analyzed by t and χ2 tests. Second, Pearson correlations were run to test for 
associations between dispositional characteristics and the main study variables (average weekly SBP, 
pain threshold, and subjective pain evaluation by the VAS). 
 
Random effects regression models (PROC MIXED; SAS Institute) examined the relation between 
repeated pain evaluations (VAS), Stimulus type (pain vs no pain), and Cardiac phase (systole vs 
diastole). To test if cardiac cycle-related pain modulation was moderated by BP, the model was 
repeated including average weekly BP for each participant as a predictor. 
 
fMRI data analysis  
Statistical inference used random effects approach (30). This comprised two steps. First, for each 
participant, data were best-fitted (least-square fit) at every voxel using a linear combination of effects 
of interest.  These encompassed the timing of sensory stimuli for each of the four event-types (given by 
crossing of the two factors): 1) pain at systole (S/P); 2) no-pain at systole (S/nP); 3) pain at diastole 
(D/P); 4) no-pain at diastole (D/nP).  Additionally, to assess the impact of the subjective pain ratings, 
the model included one regressor that modelled the onset of the VAS rating for each trial (event 
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 duration = 0) and its parametric modulator, as indexed by the numerical VAS rating of the peak pain 
intensity at each trial.  The analytic model also included head-motion realignment parameters as 
covariates of no interest.  All event-types were convolved with the SPM12 standard hemodynamic 
response function (HRF). Linear compounds (contrasts) determined the effect of the four relevant trial-
types and the parametric regressor, averaged across the two fMRI runs. 
 
Repeated-measures ANOVA was used to analyze the event-related activations associated with the 
main four event-types. The VAS and the corresponding parametric modulation were assessed using two 
separate one-sample t-tests (Text S3, Table S1, Table S2, in Supplemental Digital Content, 
http://links.lww.com/PSYMED/A463). Correction for non-sphericity was used to account for possible 
differences in error variance across conditions and any non-independent error term from repeated 
measures (31). 
 
Within the group-level ANOVA, we first assessed the overall main effect of pain by contrasting all 
pain-delivery conditions was against the no-pain conditions, irrespective of cardiac phase ([(S/P + D/P) 
> (S/nP + D/nP)] and the inverse: [(S/nP + D/nP) > (S/P + D/P)]). Moreover, we assessed the overall 
main effect of baroreceptor discharge, contrasting all conditions in which stimulation was delivered at 
systole against conditions where the stimulus was delivered at diastole, irrespective of stimulus type 
([(S/P + S/nP) > (D/P + D/nP)] and the inverse: [(D/P + D/nP) > (S/P + S/nP)]).  Second, we asked 
whether pain-related brain activity was modulated by baroreceptor discharge. We tested the interaction 
between these two factors, expecting maximal brain activity within pain-related areas at diastole, when 
the spontaneous discharge of baroreceptor was minimal; [(D/P – D/nP) > (S/P – S/nP)]. To verify 
whether cardiac cycle-related pain modulation was moderated by average weekly BP, we performed a 
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 group-level one-sample t-test (i.e., considering the contrast images for the interaction term [(D/P – 
D/nP) > (S/P – S/nP)] and entered mean BP value of each participant as covariate in the model. 
 
For these comparisons, the SPM threshold was set to p-corrected < 0.05 (Family Wise Error at the 
voxel-level) for the whole brain. 
  
ROI-based analysis 
To further interpret our results, we performed targeted region of interest (ROI) analyses.  
Specifically, we tested all pain-modulation effects in nine ROIs belonging to the “pain matrix”, 
including insula, anterior cingulate cortex (ACC), primary and secondary somatosensory areas, 
cerebellum, parietal operculum, premotor and supplementary motor cortices, amygdala and thalamus 
(32,33). ROIs were created using SPM Anatomy Toolbox version 2.2c (34). Corrected p-values for 
each ROI were assigned using a Small Volume Correction procedure, considering each ROI as volume 
of interest (35). ). P-values were Bonferroni-corrected for multiple comparisons (0.05/9). 
 
Moreover, given our prior hypothesis concerning the possible involvement of descending 
inhibitory control (i.e., PAG/RVM) on pain modulation, we used a small volume correction procedure 
to test for the effect of pain and cardiac cycle-related pain modulation specifically for this pathway. 
The search volume for this area was derived from previous work (36) centering a sphere at MNI x, y, z 
= 18 -30 -30; with a radius of 10 mm.  
 
RESULTS  
Descriptive statistics 
Participants had a mean SBP of 112.03 ± 5.95 mmHg, mean diastolic BP of 71.16 ± 6 mmHg, and 
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 a mean heart rate of 70.21± 6.4 bpm. The average pain threshold was 22.49 ± 7.15 mA. Women had 
lower BMI (21.7 ± 3.8 Kg/m
2
) compared to men (25 ± 2.7 Kg/m
2
), t(16) = 2.1; p = .05. No other sex 
differences emerged; therefore, this variable was not included as a covariate in the random-effects 
regression models. 
 
Pain catastrophizing was negatively associated with SBP (r = -0.84) and positively associated with 
subjective pain perception during painful stimulation (r = 0.47).  An inverse association emerged 
between the helplessness subscale and SBP (r = -0.91).  SBP was negatively correlated with pain 
ratings (r = -0.80) and marginally associated with pain threshold (r = 0.79). Table 1 shows Pearson 
correlations between dispositional characteristics and average weekly SBP, pain threshold, and 
subjective pain rating.   
 
Behavioral ratings 
There was a main effect of Stimulus type (F(1, 2283) = 3684.7; p < 0.0001), and a Stimulus type 
by Cardiac phase interaction, (F(1, 2283) = 4.82; p = 0.03).  Non-painful stimuli were naturally 
perceived as less painful (2.8 ± 1.9) compared to painful stimuli (6.8 ± 1.7).  Moreover, painful stimuli 
were perceived as less painful during baroreceptor discharge, i.e. at systole (6.1 ± 1.7), compared to 
diastole (6.9 ± 1.7). 
 
When individual difference in SBP was incorporated into the statistical model, a main effect of 
SBP was revealed, F(1, 2164) = 166.76; p < 0.0001, and a Stimulus type by SBP interaction, F(1, 
2164) = 10.47; p < 0.0001. Participants with higher SBP manifested lower pain perception compared to 
those with lower SBP and this was particularly true for painful stimuli. Neither Cardiac phase by SBP 
group, nor Cardiac phase by Stimulus type by SBP group (3-way) interactions emerged.  
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 FMRI 
Overall pain-related activation 
Pain stimulation enhanced activity of cortical and subcortical regions (Table 2; Figure 1A).  In the 
frontal lobe, one activation cluster extended from the lateral surface of the hemisphere to the depth of 
the central sulcus, and extended to the opposite hemisphere embracing, anteriorly, the precentral gyrus 
and, posteriorly, somatosensory areas within superior parietal lobe (Text, S1 and S2, Supplemental 
Digital Content, http://links.lww.com/PSYMED/A463).  Pain stimulation also enhanced activity within 
midcingulate cortex and prefrontal cortex, including supplementary motor cortex bilaterally.   Another 
activation cluster was located in the cerebellum and extended superiorly to occipital cortex.  Pain 
stimulation also enhanced activity within the thalamus, left amygdala, hippocampus, bilateral posterior 
insula and the right posterior cortex, including the supramarginal gyrus (SMG).  No regions showed 
significantly greater activity to the non-pain vs pain stimuli. 
 
The ROI approach revealed signal increase in the posterior insula (bilaterally), the somatosensory 
cortices, the premotor and supplementary cortices, the parietal operculum, the cerebellum and the 
thalamus. Signal increases in amygdala and middle cingulate cortex were also significant but did not 
survive Bonferroni correction (Table 3). Results also revealed signal increase in the PAG/RVM 
(maxima x,y,z = 20 -36 -24; Z-value = 4.53; p < 0.001, corrected for small volume), consistent with the 
putative pathway for descending inhibitory control of pain.  
 
Overall effect of baroreceptor discharge 
Irrespective of stimulus type, we found that, within the left parietal lobe, the postcentral gyrus, 
possibly encompassing secondary somatosensory cortex (x,y,z = -58 -10 18; z-value = 4.27; Cluster 
size: 236; p-corr = 0.016) and a cluster located in the superior parietal lobe, possibly including the 
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 primary sensory cortex (i.e., BA2) (x,y,z = -16 -50 54; z-value = 4.17; Cluster size: 186; p-corr = 
0.039) activated at ventricular systole, during spontaneous baroreceptor discharge (Figure 1B). This 
analysis did not highlight any activity within the ROI chosen to test any involvement of the descending 
inhibitory pathways. Furthermore, the comparison contrast for the effect of minimal over maximal 
baroreceptor discharge (i.e. diastole vs systole) was not significant. 
  
Cardiac cycle-related pain modulation  
Next, we tested whether neural responses to pain were selectively modulated by the cardiac phase. 
Analysis revealed no significant activation associated with modulation of pain by baroreceptor 
discharge, nor ROI-based approach highlighted engagement of regions that are known to be involved in 
pain perception, including PAG/RVM descending inhibitory pathway. Analysis exploring the impact of 
SBP variability on pain modulation did not reveal significant brain activation, suggesting that the 
cardiac cycle-related pain modulation is not affected by subtle changes in BP among our sample of 
healthy participants. Although the interaction between Stimulus type and Cardiac phase did not reveal a 
significant effect, due to its theoretical significance, we report the activation of a small cluster located 
in the right parietal cortex, likely to include the posterior division of the supramarginal gyrus (SMG: 
x,y,z = 34 -40 20; z-value = 4.10; Cluster size: 127; p-unc < .001). Specifically, we found that the 
activity within this area increased for pain stimuli delivered at diastole, and decreased significantly for 
non-pain stimuli delivered at diastole.  This result suggests that the activity within this region was 
increased when pain stimuli were presented at diastole compared to other conditions.  
 
DISCUSSION 
The present study supports the existence of a relationship between baroreceptor activation, BP and 
pain perception, in a predicted direction, i.e. pain perception is lower in the presence of elevated BP.  
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 Our data shows that the inverse relationship between BP and pain perception is not exclusive to 
hypertensive individuals but is also present in normotensives (4).  First, we observed an inverse 
correlation between basal (weekly home) SBP and lower subjective pain ratings (determining pain 
threshold) during electrical stimulation. Next, in line with the idea that BP-related hypoalgesia is 
coupled to the baroreflex, painful stimuli were generally perceived as less painful during baroreceptor 
discharge (i.e. ventricular systole). 
 
In normotensives, an association is observed between natural variations in baroreceptor activity 
across the cardiac cycle and objective nociceptive responding (19,37-39).  However, subjective pain 
ratings may not show such variation across the cardiac cycle (19,38,39) or even occur in the opposite 
direction (i.e. higher pain ratings at systole compared to diastole) (40).  To our knowledge, this is the 
second study to report reduced subjective pain perception during natural baroreceptor discharge (21).  
Our data show a main effect of cardiac phase, but not a stimulus type by phase interaction.  This may 
suggest that the influence of natural baroreceptor activation on stimulus perception extends beyond 
pain (41). However, non-painful stimuli in our study were not rated as completely free of pain.  
Moreover, the stimuli we used here had an average higher voltage compared to previous studies on this 
topic. This methodological discrepancy may partly explain divergence of results.  Further, our result is 
consistent with data on reduced pain after artificial stimulation of baroreceptors (42-44).  However, 
even this finding is variable with some studies reporting opposite effects of baroreceptors stimulation 
on pain perception (38,45,46). When BP was taken into account in the current study, pain perception, 
especially for painful stimuli, was dampened in participants with higher SBP. However, this did not 
differ based on cardiac cycle phase. Indeed, if elevated BP is caused by reduced pain perception, it is 
plausible that such progression to disease due to reduced pain sensitivity does not occur as early as in 
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 present participants‟ age or perhaps occur in those already diagnosed as hypertensive (i.e., in earlier 
onset hypertension) and therefore excluded from the study. 
 
Another recent plausible explanation that needs to be further investigated is that hypoalgesia in 
hypertension-prone individuals is explained by altered stress response rather than by differential 
baroreflex activation (47). 
 
Pain perception has specific signatures in terms of brain network activation. Thus, functional 
imaging reveals how the experience of pain is different with varying baroreceptor discharge.  
Irrespective of cardiac timing, the painful stimuli activated regions involved in processing pain, 
including somatosensory areas, prefrontal cortex, cingulate cortex, posterior insula, amygdala and 
thalamus, the primary relay for afferent transmission of nociceptive information (48).  Importantly, in 
agreement with existing literature claiming a role for descending inhibitory pathway in pain perception, 
results revealed a significant signal increase in the PAG/RVM (49). Relevant to the aim of the present 
study, most of these structures form the core of the Central Autonomic Network (CAN) (50).  
Moreover, present data support recent perspectives including cerebellar involvement in pain 
perception (51). Again, cerebellum is also implicated in autonomic regulation (52). 
 
Irrespective of stimulus type (painful or non-painful) baroreceptor discharge was mainly associated 
with activation of the left superior parietal lobule and postcentral gyrus, areas that have been associated 
with increased high-frequency power (parasympathetic) heart rate variability (53,54). 
 
Previous studies that looked at the brain correlates of BP-related hypoalgesia mostly examined the 
effects of baroreceptor stimulation by neck suction on pain-related evoked brain potentials.  Results 
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 point to the fact that stimulation of the arterial baroreceptors can modulate processing of noxious 
stimuli but results were in the opposite direction (55).  Only one study examined variations in the N2-
P2 amplitudes across the cardiac cycle and reported smaller amplitudes mid-cycle, indicating that 
cortical processing of nociception was attenuated during systole compared to diastole (20).  Gray and 
colleagues, however, found that P2 was abolished for stimuli presented during baroreceptor activation, 
but only when nociceptive stimuli were preceded by a warning cue cued, and therefore expected (56). 
The latter is the only study in which attentional and baroreceptor influences on pain were dissected and 
the authors conclude that the “analgesic” effects of baroreceptor activation obligatorily require salient 
or attentionally-focused pain (56). For completeness, it has to be noted that a number of studies still 
showed cardiac cycle effects even if stimuli were not cued but instead presented pseudo-randomly (19, 
38, 39).  Our finding of shared attention-related areas between pain perception and baroreceptor firing 
are in agreement with this conclusion and with others‟ view that largest part of the fMRI responses 
elicited by phasic nociceptive stimuli may reflect non-nociceptive-specific cognitive processes (57).  
 
In line with the view that expectancy and attention, rather than physiological habituation, modulate 
the baroreceptor gating of pain responses, attention-related brain areas were significantly more 
activated when participants reported to less pain.  In our behavioral analyses, stimuli rated as less 
painful occurred at systole.  This suggests that areas like the superior parietal lobule, precentral and 
lingual gyrus may be implicated in the association between pain perception and baroreceptor 
functioning via attentional mechanisms.  These brain regions are indeed activated by pain (58), and are 
implicated as neural substrates of parasympathetic nervous system control (59,60). 
 
In interpreting our results, one needs to be aware that in other domains, baroreceptor afferent firing 
does not have an inhibitory effect on the processing of sensory stimuli. For example, in the domain of 
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 fear subjective, behavioral, and neural responses are greater at systole and attenuated at diastole (61).  
Unfortunately, the cross-sectional design of our study does not allow drawing causal conclusions about 
the inverse associations that emerged between dispositional characteristics like pain catastrophizing 
(and particularly helplessness thoughts when experiencing pain) and BP.  Is it simply that people with 
higher BP perceive stimuli as less painful, and therefore have a less dramatic attitude toward pain?  
Intriguingly, pain catastrophizing was correlated with BP, which in turn was associated with reduced 
pain perception.  Future studies with a larger sample size should investigate pain catastrophizing as a 
potential moderator of the BP-pain relationship.  Considering that pain catastrophizing correlates with 
pain intensity of pain across chronic pain disorders, this might help clarifying the reason why BP-
hypoalgesia disappears in chronic pain. 
 
A major limitation of this study is the small sample size, which increases the likelihood that the 
estimate of the magnitude of a significant effect is exaggerated (62). Second, due to time constraints, 
pain threshold was not assessed at both systole and diastole. Third, BP was not monitored throughout 
the fMRI protocol due to technical difficulties in having reliable BP data in the scanner environment.  
This is the first study to combine MRI and peripheral physiology monitoring with the aim of 
examining the link between BP-related hypoalgesia and baroreceptor functioning, therefore results 
should be considered preliminary and need to be replicated. Present results support the existence of a 
significant association between elevated BP and reduced pain perception. Moreover, our findings 
endorse the view that, in addition to regulating BP, baroreflex mechanisms modulate activity in pain-
related brainstem areas (17). Research that elucidates the causal mechanisms underlying this 
phenomenon and its role in the pathogenesis of hypertension is highly relevant for the prevention of 
cardiovascular morbidity, the most widespread and costly health problem of the modern era. 
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 FIGURE CAPTION 
 
Figure 1. (A) Event-related responses to pain stimuli. Three-dimensional surface-rendered projections 
of the activations associated with painful vs non-painful stimulation. SPM display threshold: p 
uncorrected = 0.001, minimum cluster size = 100 voxels. See Table 2 for the statistics associated with 
the significant main effect of painful stimulation. (B) Overall effect of baroreceptor discharge. 
Horizontal section and signal plot for the region in the left superior parietal lobe (SPL) that activated 
when the spontaneous discharge of baroreceptor was maximal. The signal plot shows that activity in 
this region was increased at systole (bar 1 and 2) than diastole (bar 3 and 4), irrespective of pain 
stimulation. The level of activation for the four event types is mean-adjusted (i.e., the four values sum 
to zero) and is expressed in arbitrary units (a.u. ± 90% confidence interval). SPM display threshold: p-
unc = 0.001, minimum clusters-size = 100 voxels. 
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Table 1. Pearson correlations between dispositional characteristics and average weekly systolic blood 
pressure (SBP), pain threshold, and subjective pain evaluation (VAS). N = 18. 
 
Note. * p < .05; ** p < .0001; § p < .07. STAI = Spielberger Trait Anxiety Inventory; CESD = Center 
for Epidemiologic Studies Depression Scale; PCS = Pain Catastrophizing Scale; PCSr = Pain 
Catastrophizing Scale-Rumination; PCSm = Pain Catastrophizing Scale-Magnification; PCSh = Pain 
Catastrophizing Scale- Helplessness; BPIs = Brief Pain Inventory-Severity; BPIi = Brief Pain 
Inventory-Interference; SBP = Systolic Blood Pressure; VAS = Visual Analog Scale (during painful 
stimulation). 
 
  
 STAI CESD PCS PCSr PCSm PCSh BPIs BPIi SBP Threshold VAS 
STAI 1 .63
**
 .45
*
 .36 .41 .39 -.22 -.01 .07 .27 .07 
CESD  1 .53
*
 .59
*
 .34 .39 .07 .09 .01 .13 .15 
PCS   1 .88
**
 .75
**
 .87
**
 .10 .31 -.84
*
 .10 .47
*
 
PCSr    1 .62
**
 .61
**
 -.02 .30 -.69
§
 .15 .51
*
 
PCSm     1 .45
§
 .20 .36 -.65 .22 .50
*
 
PCSh      1 .09 .19 -.91
**
 -.07 .25 
BPIs       1 .44
§
 -.08 -.06 .20 
BPIi        1 -.07 .10 .37 
SBP         1 .79
§
 -.80
*
 
Threshold          1 .19 
VAS           1 
Copyright © 2018 by the American Psychosomatic Society. Unauthorized reproduction of this article is prohibited.
AC
CE
PT
ED
 Table 2. Overall effect of painful stimulation. N = 18. 
Contrast Pain > No Pain 
Anatomical Region Hem p-corr* Coord Z-val 
PreC  R <0.001 40 -12 54 7.32 
PostC  R <0.001 36 -22 50 6.94 
SPL R <0.001 16 -44 64 6.89 
SMA  R <0.001 4 -8 50 6.57 
aMCC R <0.001 6 12 32 6.16 
PreC  L <0.001 -22 -24 76 5.90 
SPL L <0.001 -22 -40 64 5.90 
Precuneus  L <0.001 -6 -44 62 5.90 
pMCC  R <0.001 8 -12 42 5.61 
Cerebellum  R <0.001 18 -54 -16 6.50 
Cerebellum  L <0.001 -14 -62 -14 5.91 
Lingual Gyrus  L <0.001 -8 -72 6 5.83 
Lingual Gyrus R <0.001 10 -58 -2 5.74 
Posterior Insula  L <0.001 -34 -20 8 5.64 
SMG R <0.001 52 -32 26 5.64 
Thalamus R <0.001 16 -20 10 5.59 
Hippocampus R <0.001 34 -4 -8 5.44 
Thalamus L <0.001 -14 -12 6 5.24 
Posterior Insula  R <0.001 36 -28 20 5.10 
Amygdala R <0.001 22 -2 -14 4.82 
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 Hippocampus L <0.001 -22 -24 -8 4.72 
 
Note. Pain > Non-Pain: brain regions activated by pain stimuli, as compared to non-pain stimuli 
*= p-values FWE-corrected < 0.05 (voxel level, whole brain).  Coordinates are in Montreal 
Neurological Institute Space. PreC: precentral gyrus; PostC: postcentral gyrus; SPL: superior 
parietal lobule; SMA: supplementary motor area; aMCC: anterior midcingulate cortex; pMCC: 
posterior midcingulate cortex; SMG: supramarginal gyrus. 
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 Table 3. Overall effect of painful stimulation within each region of interest (ROI). N = 18. 
Contrast Pain > No Pain 
Anatomical Region Hem p-corr* Coord Z-val 
S1 R <0.001 40 -20 48 6.61 
S2  R <0.001 28 -40 62 6.33 
Premotor Cortex (BA6)  R <0.001 40 -12 54 7.32 
Premotor Cortex (BA6) L <0.001 -22 -22 74 5.78 
Parietal Operculum R <0.001 44 -30 18 5.36 
Parietal Operculum  L <0.001 -42 -32 16 5.14 
Cerebellum R <0.001 18 -54 -16 6.50 
Cerebellum L <0.001 -16 -50 -18 6.34 
Insula L <0.001 -34 -20 8 5.64 
Insula R <0.001 34 -22 10 5.03 
Thalamus R <0.001 16 -20 10 5.59 
Thalamus  L <0.001 -14 -12 6 5.24 
Middle Cingulate Cortex R 0.014 6 12 30 5.01 
Middle Cingulate Cortex L 0.016 -4 16 26 4.42 
Amygdala R 0.010 22 -2 -16 4.72 
 
Note. Pain > Non-Pain: brain regions activated by pain stimuli, as compared to non-pain stimuli within 
nine ROIs. 
*= p-values are Bonferroni corrected for the number of the ROIs, and significance threshold 
set at p < 0.05. Statistics significant following Bonferroni adjustment for multiple comparisons 
are highlighted in bold. Coordinates are in Montreal Neurological Institute Space. 
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